Justia U.S. 3rd Circuit Court of Appeals Opinion Summaries

Following the armed robbery of a Winston-Salem, North Carolina convenience store, officers obtained a warrant for Stanford’s arrest and contacted Wilmington Detective Cannon for help apprehending Stanford, whom they believed had fled to Delaware. Cannon obtained a search warrant authorizing the use of a cell-site simulator to locate Stanford’s cell phone. Cannon alleged that Stanford was originally from Wilmington and had family members and associates who could assist him. Officers learned that Stanford was at a Wilmington Residence. While conducting surveillance, police approached a woman who exited the Residence and asked whether Stanford was there. She said Stanford and Gibson—Stanford’s brother, wanted on other charges—were inside. Officers knocked, announced, and entered the unlocked door. Stanford and Gibson were arrested. Cannon obtained a warrant to search the Residence for evidence of the North Carolina robbery. The Affidavit contained possible inaccuracies about the other suspects and Stanford's stay at the Residence. The subsequent search of the Residence yielded a loaded handgun beneath a cushion on the couch where Stanford was laying when he was arrested.Stanford was charged with illegal firearm possession 18 U.S.C. 922(g)(1), 924(a)(2). The Third Circuit affirmed the denial of his motion to suppress, based on the good faith exception to the exclusionary rule, and his sentence. Delaware first- and second-degree robbery are U.S.S.G crimes of violence. View "United States v. Stanford" on Justia Law

For many years, Zurn, a manufacturer of plumbing products and accessories, has faced multiple lawsuits in which claimants allege bodily injury or wrongful death caused by asbestos in its products. To cover litigation costs, Zurn used various insurance policies issued by various insurance companies. Eventually, Zurn was told by its primary and umbrella insurers that Zurn had exhausted the limits of liability under those policies. When Zurn’s excess policy insurers refused to pay, Zurn sought a declaratory judgment that it had exhausted the limits of liability under its primary and umbrella policies and that Zurn’s excess policy insurers had a duty to defend and pay defense costs in the underlying asbestos suits. After discovery, the district court interpreted the meaning of various primary, umbrella, and excess policies, and determined the scope of some duties insurers have under them.One excess policy insurer—American Home—appealed several partial summary judgment orders. The Third Circuit dismissed the appeal for lack of jurisdiction. American Home does not challenge orders that are functionally equivalent to an injunction, No part of the declaration-granting orders compels American Home “to undertake the defense” of Zurn. View "Zurn Industries Inc v. Allstate Insurance Co" on Justia Law

Mylan regularly submitted abbreviated new drug applications (ANDAs) to the FDA, often including Paragraph IV certifications stating that the proposed generic drug at issue would not infringe valid patents. Mylan incurred tens of millions of dollars in legal fees defending itself in about 120 patent infringement suits, 35 U.S.C. 271(e)(2). Mylan incurred additional, much lower legal fees in preparing the notice letters associated with the Paragraph IV certifications. Mylan's fees were $46,158,403, $38,211,911, and $38,618,993 during 2012, 2013, and 2014, respectively, for preparing notice letters and litigating the ANDA suits. In tax filings, Mylan deducted those amounts in the years incurred. The IRS responded that Mylan could not deduct the nearly $130 million of legal expenses incurred from 2012-2014 and that its additional tax liability was about $50 million.The Tax Court considered expert testimony regarding internal FDA processes and the typical course of dealing between an ANDA applicant and the FDA during the submission process for an ANDA with a paragraph IV certification and held that the legal expenses Mylan incurred to prepare notice letters were required to be capitalized because they were necessary to obtain FDA approval of its generic drugs. The Third Circuit affirmed its holding that the legal expenses incurred to defend patent infringement suits were deductible as ordinary and necessary business expenses because the patent litigation was distinct from the FDA approval process. View "Mylan Inc v. Commissioner of Internal Revenue" on Justia Law

The Center for Biological Diversity challenged the Environmental Protection Agency’s approval of certain air pollution control technology for use at various Pennsylvania industrial facilities. The Center argues that the EPA violated the Clean Air Act, 42 U.S.C. 7401, by focusing exclusively on emissions from those facilities instead of examining their impact on air quality more generally and that, even if the EPA is permitted to base its approvals on an emissions-only analysis, it incorrectly concluded that emissions would not be increased by Pennsylvania’s pollution control technologies at issue.The Third Circuit denied petitions for review, interpreting the relevant statutory provisions to permit the EPA’s chosen emissions-based approach. The court reasoned that emissions were the sole air quality variable implicated by Pennsylvania’s revisions of its state implementation plan under the Act; it was therefore not arbitrary for the EPA to use an emissions-based analysis. It was not arbitrary for the EPA to use prior permitting standards, instead of presumptive Reasonably Available Control Technology (RACT), as the emissions baseline for its comparative emissions analysis. The Center’s alternative challenges were procedurally and substantively deficient. View "Center for Biological Diversity v. United States Environmental Protection Agency" on Justia Law

The owner and CEO of Southern Pines (Pat) recruited Kairys as Vice President of Sales to grow the company’s cryogenic trucking services. Soon after he started the job, Kairys required hip replacement surgery. Kairys had surgery and missed seven days of work. Southern was self-insured. Kairys’s surgery caused its health insurance costs to rise markedly. According to Kairys, after he returned to work, Pat’s brother (the VP) told him to “lay low” because Pat was upset. Four months later, Pat fired Kairys, claiming that Southern had “maxed out” its sales potential in cryogenic trucking. Weeks later, Souther hired a part-time worker in a hybrid role that included work that had been done by Kairys.Kairys sued, alleging discrimination and retaliation, citing the Americans with Disabilities Act, the Age Discrimination in Employment Act, the Employee Retirement Income Security Act (ERISA), 29 U.S.C. 1001, and state laws. A jury rejected Kairys’s ADA and ADEA claims and returned an advisory verdict for Southern on the ERISA claim.The district court independently considered the ERISA claim and found that Kairys had proved retaliation for using ERISA-protected benefits and interfered with his right to future benefits. The court awarded Kairys $67,500 in front pay and $111, 981.79 in attorney fees. The Third Circuit affirmed. The judgment for Kairys on the ERISA claim was not inconsistent with the jury’s verdict on the other claims and was supported by sufficient evidence. View "Kairys v. Southern Pines Trucking, Inc" on Justia Law

Port Hamilton Refinery purchased an existing St. Croix petroleum refinery at a 2021 bankruptcy auction, hoping to resume operations. The Refinery had for decades served as the backbone of St. Croix’s local economy until it ceased operations in 2012. Months later, the EPA notified Port Hamilton that it would need a Prevention of Significant Deterioration (PSD) permit before the Refinery could resume operations.The PSD program is part of the Clean Air Act (CAA); a facility must not contribute to the violation of applicable air quality standards and must implement the “best available control technology” to limit air pollution, 42 U.S.C. 7475(a), 7479(3). PSD applies to newly constructed stationary sources of air pollution and sources that undergo emissions-altering modifications. Under EPA’s “Reactivation Policy,” an existing facility is “new” if EPA concludes that it had previously been “shut down” and restarted. If the EPA determines that the facility had only been “idled,” it need not obtain a permit.In 2018, EPA notified the Refinery’s prior owner that it need not obtain a PSD permit because the Refinery had been only “idled” since 2012. In 2022, EPA reversed course. The Third Circuit vacated the EPA decision. The Reactivation Policy, as applied to the Refinery, exceeds EPA’s statutory authority. View "Port Hamilton Refining and Transportation LLLP v. United States Environmental Protection Agency" on Justia Law

Gillette, a serial sex offender, received a 27-year sentence for sex crimes. After his release, he never registered as a sex offender. On a tip, law enforcement found that Gillette had been living with a 15-year-old boy and had engaged in sexual contact with that child and another child. Gillette was convicted on 20 counts of territorial-law offenses; federal charges were dismissed. The court sentenced Gillette to 155 years’ imprisonment. The Third Circuit affirmed.Gillette filed a habeas petition in the Virgin Islands Superior Court. At Gillette’s request, the Superior Court issued a subpoena duces tecum to the U.S. Attorney’s Office (USAO). As required by Department of Justice regulations, the USAO requested that Gillette submit “a summary of the information” sought “and its relevance to the proceeding.” Gillette instead moved for contempt and sanctions against the USAO for failing to respond to his subpoena. The USAO then removed the proceedings to federal court and successfully moved to quash the subpoena. The Third Circuit dismissed Gillette’s appeal for lack of jurisdiction. The government never waived its sovereign immunity concerning non-monetary actions against it, so the Superior Court lacked jurisdiction over the USAO; the district court derived its jurisdiction over Gillette’s subpoena-enforcement action from 28 U.S.C. 1442(a)(1) and also lacked jurisdiction. View "Gillette v. Golden Grove Adult Correctional Facility" on Justia Law

Johnsonburg, Pennsylvania Officer Cuneo learned that the St. Marys Police Department had a search warrant to obtain a DNA sample from Perez. Cuneo knew Perez, a local with a history of illegal drug use. A log entry instructed officers who saw Perez to “hold” him and call St. Marys. Cuneo knew that Perez’s DNA had been found at the scene of a recent drug house burglary. Cuneo inferred—mistakenly—that a “body” warrant also had been issued. Later, sitting in his cruiser, Cuneo spotted Perez. The men stood on the sidewalk, having a “friendly conversation.” When Cuneo mentioned the DNA warrant and told Perez he needed to take him into custody. Perez said he was going home and sprinted away.Cuneo pursued Perez. Perez says he was tased from behind without warning. Cuneo says he warned Perez to stop before tasing him. Perez fell forward, breaking his nose. Cuneo radioed for backup and medical assistance. Perez recovered; a physical altercation ensued. Cuneo repeatedly tased and struck Perez with his baton, then shot Perez in the back.In a suit under 42 U.S.C. 1983, Cuneo asserted qualified immunity in defense. The court denied Cuneo’s summary judgment motion as to his use of his firearm and the unlawful seizure claim. The Third Circuit reversed in part. Cuneo did not seize Perez during their initial encounter. The court remanded so Perez’s excessive force claim for Cuneo’s use of his firearm can proceed. View "Perez v. Borough of Johnsonburg" on Justia Law

Vepuri is the de facto director of KVK-Tech, a generic drug manufacturer. He employed Panchal as its director of quality assurance. KVK-Tech manufactured and sold Hydroxyzine, a prescription generic drug used to treat anxiety and tension. The government alleges that Vepuri, Panchal, and KVK-Tech sourced active ingredient for the Hydroxyzine from a facility (DRL) that was not included in the approvals that they obtained from the FDA and that they misled the FDA about their practices.An indictment charged all three defendants with conspiracy to defraud and to commit offenses against the United States and charged KVK-Tech with an additional count of mail fraud. The district court dismissed the portion of the conspiracy charge that alleges that the three conspired to violate the Food, Drug, and Cosmetic Act (FDCA), which prohibits introducing a “new drug” into interstate commerce unless an FDA approval “is effective with respect to such drug,” 21 U.S.C. 355(a).The Third Circuit affirmed, rejecting an argument that a deviation from the approved drug application means that the approval is no longer effective. The approval ceases being effective only when it has been withdrawn or suspended. The indictment does not include any allegations that the KVK-Tech Hydroxyzine manufactured with active ingredients from DRL had a different composition or labeling than the KVK-Tech Hydroxyzine with the effective approval. View "United States v. Vepuri" on Justia Law

An Asset Purchase Agreement provided that the sellers could receive variable payments (Earn-Out Consideration) if the post-merger company (IAS) achieved specific benchmarks. Section 2.6(c) specifies that IAS had to provide the sellers with the computation for each period, to become final unless they submitted a “notice of disagreement.” Any disagreement would be settled according to Section 2.3(e),” which refers to resolution by an accounting firm. Section 11.17, however, directs the parties generally to use non-binding mediation, followed by litigation if mediation fails.IAS determined that the company did not meet its targets. The sellers claim that IAS intentionally prevented the company from hitting its targets. Negotiations failed. The sellers sued for breach of contract and tortious interference; later, they filed a notice of disagreement and sought a declaration that the lawsuit was outside the scope of sections 2.3(e) and 2.6(d). IAS sought to compel arbitration under 2.3(e). The district court held that the Agreement contained a valid agreement to arbitrate. An accounting firm subsequently determined that the sellers had no right to Earn-Out Consideration. The district court entered judgment for IAS.The Third Circuit vacated. The Purchase Agreement contains an agreement to submit narrow disputes to an accounting firm for expert determination, not arbitration. Although the statement of IAS’s financial benchmarks becomes final after the expert completes its accounting analysis, the authority to resolve legal questions—like whether IAS violated the duty of good faith— remains with the courts. View "Sapp v. Industrial Action Services LLC" on Justia Law